avapritinib
blueprint medicines
['pathfinder', 'avapritinib']
 wonderful presentation of first line therapy with avapritinib in the pathfinder study, 76% had sm-ahm overall 32% achieved cr or crh 
Mum, clinician, haematologist, educator. Views my own.